Skip to main content
. Author manuscript; available in PMC: 2021 Dec 2.
Published in final edited form as: Ann Surg Oncol. 2021 Apr 15;28(7):3480–3489. doi: 10.1245/s10434-021-09804-3

Table 4.

Multivariate models of outcome

HR (95% CI) p-value
Non-nodal locoregional control
Microsatellites 3.4 (1.4–8.2) 0.009
LVI 2.7 (1.1–6.4) 0.023
Nodal disease control
LVI 3.84 (1.90–7.76) <0.005
≥2 nodes 2.14 (1.07–4.26) 0.03
>1 mm node 2.21 (1.00–4.92) 0.04
Distant disease control
LVI 2.24 (1.04–4.82) 0.039
≥2 nodes 2.51 (1.15–5.48) 0.023
>1 mm node 2.51 (1.00–6.60) 0.048
Disease-free survival
LVI 2.36 (1.32–4.23) 0.0037
>1 mm node 2.29 (1.23–4.22) 0.0057
Microsatellites 2.73 (1.48–5.02) 0.0023
Age ≥65 1.87 (1.06–3.30) 0.026

Abbreviations: CI, confidence interval; HR, hazard ratio; LVI, lymphovascular invasion.